HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment with phenylbutyrate in a pre-clinical trial reduces diarrhea due to enteropathogenic Escherichia coli: link to cathelicidin induction.

Abstract
Treatment of shigellosis in rabbits with phenylbutyrate reduces clinical severity and counteracts down-regulation of cathelicidin (CAP-18) in the large intestinal epithelia. We aimed to further evaluate whether in a rabbit model of enteropathogenic Escherichia coli (EPEC) diarrhea, CAP-18 is down-regulated in the small intestine and if oral phenylbutyrate treatment affects CAP-18 expression, clinical recovery, shedding of EPEC in stool and virulence properties of the isolated colonies. EPEC-induced diarrhea down-regulated CAP-18 in the small intestinal epithelia as revealed by immunohistochemistry. Phenylbutyrate treatment reduced clinical illness, improved histological features of inflammation and up-regulated CAP-18 in the epithelia. Active CAP-18 peptide was also released in the stool as noted in Western blot analysis. Multiplex PCR analysis of total bacterial DNA in the stool showed absence of EPEC specific genes eae and bfpA. Treated rabbits shed rough strains still harboring eae and bfpA genes, which were less potent in binding to HeLa cells and induced delayed onset of diarrhea in new rabbits. In conclusion, EPEC-mediated down-regulation of CAP-18 in the small intestinal epithelia was restored by phenylbutyrate treatment. Upregulation of CAP-18 in the epithelia was accompanied by healing of the epithelial lining, reduced shedding and virulence of EPEC and recovery from diarrhea.
AuthorsAbdullah Al-Mamun, Akhirunnessa Mily, Protim Sarker, Snigdha Tiash, Armando Navarro, Mahmuda Akter, Kaisar Ali Talukder, Mohammad Faizul Islam, Birgitta Agerberth, Gudmundur H Gudmundsson, Alejandro Cravioto, Rubhana Raqib
JournalMicrobes and infection (Microbes Infect) Vol. 15 Issue 13 Pg. 939-50 (Nov 2013) ISSN: 1769-714X [Electronic] France
PMID24016414 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antimicrobial Cationic Peptides
  • Immunologic Factors
  • Phenylbutyrates
  • Cathelicidins
Topics
  • Administration, Oral
  • Animals
  • Antimicrobial Cationic Peptides (antagonists & inhibitors, immunology)
  • Bacterial Shedding
  • Diarrhea (drug therapy, immunology, microbiology, pathology)
  • Disease Models, Animal
  • Enteropathogenic Escherichia coli (immunology)
  • Escherichia coli Infections (drug therapy, immunology, microbiology, pathology)
  • Feces (microbiology)
  • Gene Expression Profiling
  • Immunologic Factors (therapeutic use)
  • Intestine, Small (immunology, pathology)
  • Phenylbutyrates (therapeutic use)
  • Rabbits
  • Treatment Outcome
  • Cathelicidins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: